Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease

Clinical Nephrology

Volumn 70, Issue 2, 2008, Pages 144-154

  Thaha, M ^a   Pranawa, ^a   Yogiantoro, M ^a   Sutjipto, ^b   Sunarjo, ^b   Tanimoto, M ^c   Gohda, T ^c   Tomino, Yasu ^c  

^a University School of Medicine   (Indonesia)

^b AIRLANGGA UNIVERSITY   (Indonesia)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

End stage renal disease (ESRD); Endothelial nitric oxide synthase (eNOS); Gene polymorphism; Polymerase chain reaction

Indexed keywords

ASPARTIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HEMODIALYSIS; HOMOZYGOSITY; HUMAN; HYPERTENSION; INDONESIA; KIDNEY FAILURE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT;

EID: 48749115852     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp70144     Document Type: Article

References (40)

1. Asakimori Y, Yorioka N, Taniguchi Y, Takasugi N, Harada S, Shigemoto K, Yamashita K, Usui. K, Arita M, Kohno N. (T-786)C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron. 2002; 91: 747-751.
2. Cai H, Wilcken DE, Wang XL. The Glu-298→Asp (894G→T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med. 1999; 77: 511-514.
3. Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC. Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)→Asp variant of human endothelial nitric-oxide synthase. J Biol Chem. 2001; 276: 26674-26679.
4. Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden DW. Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol Dial Transplant. 2000; 15: 1794-1800.
5. Fujita H, Narita T, Meguro H, Ishii T, Hanyu O, Suzuki K, Kamoi K, Ito S. Lack of association between an ecNOS polymorphism and diabetic nephropathy in Type 2 diabetes patients with proliferative diabetic retinopathy. Horm Metab Res. 2000; 32: 80-83.
6. Golser R, Gorren ACF, Mayer B, Schmidt K. Functional characterization of Glu298Asp mutant human endothelial nitric oxide synthase purified from a yeast expression system. Nitric Oxide. 2003; 8: 7-14.
7. Guzik TJ, Black E, West NE, McDonald D, Ratnatunga C, Pillai R, Channon KM. Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis. Am J Med Genet. 2001; 100: 130-137.
8. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T, Ochiai H, Kosuge M, Watanabe Y, Yoshii Y, Kihara M, Kimura K, Ishii M, Umemura S et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension. 1998; 32: 521-526.
9. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ. A common variant of the endothelial nitric oxide synthase (Glu→298) is a major risk factor for coronorary artery disease in the UK. Circulation. 1999; 100: 1515-1520.
10. Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, Jones C, Lonn E, Charbonnesu F, Anderson TJ. The T-786C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension. 2002; 39: 919-922.
11. Joki N, Hase H, Ishikawa H, Fukazawa C, Nakamura R, Imamura Y, Tanaka Y, Saijyo T, Fukazawa M, Yamaguchi T. Coronary artery disease as a definitive risk factor of short-time outcome after starting hemodialyis in diabetic renal failure patients. Clin Nephrol. 2001; 55: 109-114.
12. Lembo G, DeLuca N, Battagli C, Iovino G, Aretini A, Musicco M, Frati G, Pompeo F, Vecchione C, Trimaro B. A common variant of endothelial nitric oxide synthase (Glu298asp) is an independent risk factor for carotid atherosclerosis. Stroke. 2001; 32: 735-740.
13. Markus HS, Ruigrok Y, Ali N, Powell JF. Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma. Stroke. 1998; 29: 1908-1911.
14. Marsden PA, Heng HH, Scherer SW, Shimasaki Y, Ogawa H, Kugiyama K, Saito Y, Miyamoto Y, Ogawa Y, Kaneshige T, Hiramatsu H, Yoshioka T, Kamitani S, Teraoka H, Nakao K et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993; 268: 17478-17488.
15. McDonald DM, Alp NJ, Channon KM. Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics. 2004; 14: 831-839.
16. McMillan MA, Briggs JD, Junor BJ. Outcome of renal replacement treatment in patients with diabetes mellitus. BMJ. 1990; 301: 540-544.
17. McNamara DM, Holubkov R, Postava L, Ramani R, Janosko K, Mathier M, MacGowan GA, Murali S, Feldman AM, London B et al. Effect of the Asp298 variant endothelial nitric oxide synthase on survival for patients with congestive heart disease. Kidney Int. 2004; 67: 321-329.
18. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamanaka I, Takahashi N, Kaneshige T, Teraoka H, Akamizu T, Azuma N, Yoshimasa Y, Yoshimasa T, Itoh H, Masuda I, Yasue H, Nakao K. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension. 1998; 32: 3-8.
19. Naber CK, Baumgart D, Altmann C, Siffert W, Erbel R, Heusch G. eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia. Am J Physiol Heart Circ Physiol. 2001; 281: H1908-H1912.
20. Neugebauer S, Baba T, Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in Type 2 diabetes. Diabetes. 2000; 49: 500-503.
21. Noiri E, Satoh H, Taguchi J, Brodsky SV, Nakao A, Ogawa Y, Nishijima S, Yokomizo K, Takunaga K, Fujita T. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension. 2002; 40: 535-540.
22. Philip I, Plantefeve G, Vuillaumier-Barrot S, Vicaut E, LeMarie C, Henrion D, Poirier O, Levy BI, Desmonts JM, Durand G, Benessiano J. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation. 1999; 99: 3096-3098.
23. Piper GM. Enhanced, unaltered and impaired nitric oxide-mediated endothelium dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia. 1999; 42: 204-213.
24. Poirier O, Mao C, Mallet C, Nicaud V, Herrmann SM, Evans A, Ruidavets JB, Arveiler D, Luc G, Tiret L, Soubrier F, Cambien F et al. Polymorphisms of the endothelial nitric oxide synthase gene - no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest. 1999; 29: 284-290.
25. Prabhakar SS. Role of nitric oxide in diabetic nephropathy. Semin Nephrol. 2004; 24: 333-344.
26. Rossi GP, Taddei S, Virdis A, Cavallin M, Ghiadoni L, Favilla S, Versari D, Sudano I, Pessina AC, Salvetti A. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol. 2003; 41: 938-945.
27. Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus Santos JE. Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis. 2006; 186: 428-432.
28. Shin Y, Baek HS, Chang YK, Park WC, Yang WC, Bang KB. Relation between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res Clin Pract. 2004; 65: 257-265.
29. Sim AS, Wang J, Wilcken XL, Wang XL. MspI polymorphism in the promoter of the human endothelial constitutive NO synthase gene in Australian Caucasian population (letter). Mol Genet Metab. 1998; 65: 62.
30. Sugimoto H, Shikata K, Matsuda M et al. Increased expression of endothelial cell nitric oxide synthase (eNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia. 1998; 41: 1426-1434.
31. Suzuki H, Nagase S, Kikuchi S, Wang Y, Koyama A. Association of a missense Glu298Asp mutation of the endothelial nitric oxide synthase gene with end-stage renal disease. Clin Chem. 2000; 11: 1858-1860.
32. Tanus-Santos JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics. 2001; 11: 719-725.
33. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci. 2000; 97: 2832-2835.
34. Testa A, Spoto B, Tripepi G. The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease. J Hypertens. 2005; 23: 1825-1830.
35. Yang Z, Ming X. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res. 2006; 1: 53-65. Marshfield Clinic. Available from http://www.clinmedres.org/.
36. Yoon Y, Song J, Hong SH, Kim JQ. Plasma nitric oxide concentration and nitric oxide synthase gene polymorphism in coronary artery disease. Clin Chem. 2000; 46: 1626-1630.
37. Yoshimura T, Yoshimura M, Tabata A, Shimasaki Y, Nakayama M, Miyamoto Y, Saito Y, Nakao K, Yasue H, Okamura H. Association for the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Invest. 2000; 7: 238-241.
38. Yoshimura M, Yasue H, Nakayama Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y, Miyamoto Y, Nakao K. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 1998; 103: 65-69.
39. Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS. Risk of advanced diabetic nephropathy in Type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 2000; 57: 405-413.
40. Zintzaras E, Kitsios G, Stefanidis I. Endothelial NO synthase gene polymorphisms and hypertension. A metaanalysis. Hypertension. 2006; 48: 700-710.